| Literature DB >> 32372055 |
Awraris Getachew1,2, Tessema Aynalem Abejew1,2, Jiangli Wu1, Jin Xu1, Huimin Yu1, Jing Tan1, Pengjie Wu1, Yangyang Tu1, Weipeng Kang1, Zheng Wang1, Shufa Xu3.
Abstract
Chalkbrood disease is caused by Ascosphaera apis which severely affects honeybee brood. Spore inoculation experiments shown pathogenicity varies among different strains and mutants, however, the molecular mechanism of pathogenicity is unclear. We sequenced, assembled and annotated the transcriptomes of wild type (SPE1) and three mutants (SPE2, SPE3 and SPE4) with reduced pathogenicity that were constructed in our previous study. Illumina sequencing generated a total of 394,910,604 clean reads and de novo Trinity-based assembled into 12,989 unigenes, among these, 9,598 genes were successfully annotated to known proteins in UniProt database. A total of 172, 3,996, and 650 genes were up-regulated and 4,403, 2,845, and 3,016 genes were down-regulated between SPE2-SPE1, SPE3-SPE1, and SPE4-SPE1, respectively. Overall, several genes with a potential role in fungal pathogenicity were detected down-regulated in mutants including 100 hydrolytic enzymes, 117 transcriptional factors, and 47 cell wall related genes. KEGG pathway enrichment analysis reveals 216 genes involved in nine pathways were down-regulated in mutants compared to wild type. The down-regulation of more pathways involved in pathogenicity in SPE2 and SPE4 than SPE3 supports their lower pathogenicity during in-vitro bioassay experiment. Expression of 12 down-regulated genes in mutants was validated by quantitative real time PCR. This study provides valuable information on transcriptome variation caused by mutation for further functional validation of candidate pathogenicity genes in A. apis.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32372055 PMCID: PMC7200787 DOI: 10.1038/s41598-020-64022-3
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Summary of sequences analysis.
| Sample | Raw reads | Clean reads | Mapped reads | Percentage of total reads | Clean bases (Gb) | Q20 (%) | Q30 (%) | GC (%) |
|---|---|---|---|---|---|---|---|---|
| SPE1–1 | 48349304 | 37105430 | 26438255 | 54.68 | 7.25 | 99.95 | 99.6 | 40.5 |
| SPE1–2 | 41845696 | 30077548 | 21464648 | 51.29 | 6.28 | 99.95 | 99.55 | 40.5 |
| SPE1–3 | 40884398 | 31540444 | 22643882 | 55.39 | 6.13 | 99.95 | 99.65 | 40.5 |
| SPE2–1 | 35598878 | 28872174 | 20453258 | 57.45 | 5.34 | 99.95 | 99.7 | 39.5 |
| SPE2–2 | 35768122 | 29357398 | 20893501 | 58.41 | 5.37 | 99.95 | 99.7 | 39.5 |
| SPE2–3 | 34363944 | 28938056 | 20503537 | 59.67 | 5.15 | 99.95 | 99.7 | 39.5 |
| SPE3–1 | 47172926 | 38797772 | 27184234 | 57.63 | 7.08 | 99.9 | 99.55 | 40.5 |
| SPE3–2 | 46434824 | 37086102 | 26465041 | 56.99 | 6.97 | 99.95 | 99.8 | 40.5 |
| SPE3–3 | 42874686 | 34390720 | 24481896 | 57.10 | 6.43 | 99.95 | 99.7 | 40 |
| SPE4–1 | 41120690 | 34729034 | 24769384 | 60.24 | 6.17 | 99.95 | 99.7 | 42 |
| SPE4–2 | 38580564 | 32795348 | 23255301 | 60.28 | 5.79 | 99.95 | 99.75 | 42 |
| SPE4–3 | 37590610 | 31220578 | 22272348 | 59.25 | 5.64 | 99.95 | 99.7 | 42 |
| Summary | 490584642 | 394910604 | 73.6 |
Statistics of transcriptome assembly and predicted unigenes.
| Variable | Trinity | Corset |
|---|---|---|
| Number | 284718 | 12989 |
| Size of data (bp) | 343788237 | 9857448 |
| Minimum length (bp) | 201 | 201 |
| Maximum length (bp) | 17892 | 5077 |
| Mean length (bp) | 1207.469 | 758.9074 |
| N50 length (bp) | 2334 | 853 |
| GC content | 43.24 | 55.58 |
Figure 1KEGG categories mapped from the annotated proteins. The vertical axis lists the names of pathways in the KEGG database, and the horizontal axis shows the proportion of annotated genes in each pathway.
Figure 2Differentially expressed genes (DEGs): (a) Venn-diagram of down regulated, (b) Venn-diagram of up-regulated genes, (c) DEGs between SPE2-SPE1, (d) DEGs between SPE3-SPE1, (e) DEGs between SPE4-SPE1, (f) DEGs between SPE3-SPE2, and (g) DEGs between SPE4-SPE3.
The 10 most up- and down-regulated genes in A. apis genes (SPE2-SPE1).
| Comparison | Gene ID | Type | Log2 (FC) | Description |
|---|---|---|---|---|
| SPE2-SPE1 | Cluster-7978.0 | Up | 9.00 | S9VMK0, Triosephosphate isomerase |
| SPE2-SPE1 | Cluster-10688.0 | Up | 8.74 | A0A167PS18, Glycerol 2-dehydrogenase |
| SPE2-SPE1 | Cluster-10311.1 | Up | 8.61 | A0A167T893,60 S ribosomal protein |
| SPE2-SPE1 | Cluster-10513.0 | Up | 8.61 | A0A167VQB3,60 S ribosomal protein L36 |
| SPE2-SPE1 | Cluster-10697.0 | Up | 8.01 | A0A161ZCJ3, Uncharacterized protein |
| SPE2-SPE1 | Cluster-10577.0 | Up | 7.91 | A0A167SPY0, Acetyltransferase component of pyruvate dehydrogenase complex |
| SPE2-SPE1 | Cluster-10542.0 | Up | 7.89 | A0A167VG04, Putative redox protein |
| SPE2-SPE1 | Cluster-10419.0 | Up | 7.78 | A0A167YBY5, High mobility group protein |
| SPE2-SPE1 | Cluster-10672.0 | Up | 7.65 | A0A117NLB1, Uncharacterized protein |
| SPE2-SPE1 | Cluster-10559.0 | Up | 7.50 | A0A1V6NC47, Uncharacterized protein |
| SPE2-SPE1 | Cluster-5822.1 | Down | −11.19 | A0A179HTK0, Transmembrane GTPase Fzo1 |
| SPE2-SPE1 | Cluster-6486.1 | Down | −10.76 | A0A179GBQ6, C2HC5 finger protein |
| SPE2-SPE1 | Cluster-6028.0 | Down | −10.49 | A0A2C5YSX2, Uncharacterized protein |
| SPE2-SPE1 | Cluster-7741.0 | Down | −10.47 | A0A179GJ91, Vacuolar sorting protein 1 |
| SPE2-SPE1 | Cluster-9111.0 | Down | −10.33 | A0A179GE34, Trehalase |
| SPE2-SPE1 | Cluster-7335.0 | Down | −10.30 | A0A179GI75, Methylenetetrahydrofolate Reductase |
| SPE2-SPE1 | Cluster-6407.0 | Down | −10.28 | A0A179HFX0, T-complex protein 1 subunit |
| SPE2-SPE1 | Cluster-5298.0 | Down | −10.21 | A0A179GJM7, Las1-like domain-containing Protein, A0A179H6R8, Las1-like protein |
| SPE2-SPE1 | Cluster-8155.0 | Down | −10.21 | A0A179GP36, Phospholipid:diacylglycerol Acyltransferase |
| SPE2-SPE1 | Cluster-8518.0 | Down | −10.19 | A0A179HHE4, Conserved membrane protein |
The 10 most up- and down-regulated genes in A. apis genes (SPE3-SPE1).
| Comparison | Gene ID | Type | Log2 (FC) | Description |
|---|---|---|---|---|
| SPE3-SPE1 | Cluster-4091.0 | Up | 12.75 | T0KQB0, AhpC/TSA family protein |
| SPE3-SPE1 | Cluster-851.0 | Up | 11.17 | |
| SPE3-SPE1 | Cluster-4506.0 | Up | 10.44 | A0A0F2MHU1, C6 zinc finger domain containing protein, R8BH37, Putative fungal specific transcription factor domain-containing protein |
| SPE3-SPE1 | Cluster-10511.0 | Up | 10.43 | R8BGV6, Putative integral membrane protein |
| SPE3-SPE1 | Cluster-9946.0 | Up | 10.40 | A0A1Q8RX65, Uncharacterized protein |
| SPE3-SPE1 | Cluster-3385.0 | Up | 10.38 | R8BMG1, Putative hsp20-like protein |
| SPE3-SPE1 | Cluster-2451.0 | Up | 10.32 | R8BTA4, Uncharacterized protein |
| SPE3-SPE1 | Cluster-2925.0 | Up | 10.32 | A0A167N866, Mannan endo-1,6-alpha-mannosidase |
| SPE3-SPE1 | Cluster-3992.1 | Up | 10.31 | R8BKG6, Cystathionine beta-synthase |
| SPE3-SPE1 | Cluster-961.0 | Up | 10.24 | R8BQU1, Putative bleomycin hydrolase protein |
| SPE3-SPE1 | Cluster-8267.0 | Down | −9.60 | B8NCK6, Sensor histidine kinase/response regulator TcsB/Sln1, putative |
| SPE3-SPE1 | Cluster-7392.0 | Down | −9.49 | I7ZXW6, Uncharacterized protein |
| SPE3-SPE1 | Cluster-6719.0 | Down | −9.15 | I8IMJ4, Cell cycle control protein |
| SPE3-SPE1 | Cluster-10038.0 | Down | −9.10 | Q5VDD7, OmtA A0A0D9MSH1, O-methyltransferase |
| SPE3-SPE1 | Cluster-9472.0 | Down | −8.96 | A0A0D9MV28, Uncharacterized protein |
| SPE3-SPE1 | Cluster-5863.0 | Down | −8.87 | A0A0D9MRT4, Uncharacterized protein |
| SPE3-SPE1 | Cluster-5703.0 | Down | −8.76 | A0A0D9N9B4, Uncharacterized protein |
| SPE3-SPE1 | Cluster-8855.0 | Down | −8.74 | B8ND83, Uncharacterized protein |
| SPE3-SPE1 | Cluster-9835.0 | Down | −8.72 | A0A0D9MUG0, Uncharacterized protein |
| SPE3-SPE1 | Cluster-9583.0 | Down | −8.66 | A0A0D9N055, Domain found in IF2BIF5 |
The 10 most up- and down-regulated genes in A. apis genes (SPE4-SPE1).
| Comparison | Gene ID | Type | Log2 (FC) | Description |
|---|---|---|---|---|
| SPE4-SPE1 | Cluster-3360.0 | Up | 9.21 | A0A0F7ZQT7, Uncharacterized protein |
| SPE4-SPE1 | Cluster-3261.0 | Up | 8.92 | A0A179HFS8, Uncharacterized protein |
| SPE4-SPE1 | Cluster-4329.0 | Up | 8.76 | A0A179HVY6, Phosphatidylinositol 3 |
| SPE4-SPE1 | Cluster-1247.0 | Up | 8.39 | A0A179FQD2, Allantoate permease |
| SPE4-SPE1 | Cluster-9153.1 | Up | 8.20 | A0A179H215, SWIM zinc finger protein |
| SPE4-SPE1 | Cluster-2784.0 | Up | 8.19 | |
| SPE4-SPE1 | Cluster-802.1 | Up | 8.13 | |
| SPE4-SPE1 | Cluster-1720.1 | Up | 8.03 | |
| SPE4-SPE1 | Cluster-1071.0 | Up | 7.82 | |
| SPE4-SPE1 | Cluster-1025.0 | Up | 7.64 | A0A179GDN0, Proteinase aspergillopepsin II |
| SPE4-SPE1 | Cluster-8390.0 | Down | −11.89 | B8NCX4, Fasciclin domain family protein |
| SPE4-SPE1 | Cluster-9725.0 | Down | −11.49 | Q2U575, Uncharacterized protein |
| SPE4-SPE1 | Cluster-10301.0 | Down | −10.65 | B8MYB6, Uncharacterized protein |
| SPE4-SPE1 | Cluster-9556.0 | Down | −10.61 | |
| SPE4-SPE1 | Cluster-7766.0 | Down | −10.37 | |
| SPE4-SPE1 | Cluster-10318.0 | Down | −10.32 | B8NDW9, Cell cycle checkpoint protein |
| SPE4-SPE1 | Cluster-10251.0 | Down | −10.20 | I8U1U4, Uncharacterized protein A0A1S9DAJ4, Uncharacterized protein |
| SPE4-SPE1 | Cluster-6556.0 | Down | −10.19 | I8IPA8, Uncharacterized protein A0A1Z5T6S4, Uncharacterized protein |
| SPE4-SPE1 | Cluster-10407.0 | Down | −10.16 | A0A0D9N8T6, Amino acid permease |
| SPE4-SPE1 | Cluster-9672.0 | Down | −10.15 | B8NRN8, Uncharacterized protein B8NRN8, Uncharacterized protein |
Figure 3Venn diagram of DEGs for GO terms: (a) down regulated GO terms & (b) up-regulated GO terms.
KEGG pathway enrichment of DEGs.
| Comparison | Pathway | Pathway ID | DEGs-Size | Size | RF | P value |
|---|---|---|---|---|---|---|
| SPE2-SPE1-Dw | Proteasome | tve03050 | 28 | 33 | 1.55 | 0.014 |
| SPE2-SPE1-Dw | Glycine, serine and threonine metabolism | tve00260 | 28 | 36 | 1.42 | 0.028 |
| SPE2-SPE1-Dw | Aminoacyl-tRNA biosynthesis | tve00970 | 31 | 43 | 1.31 | 0.040 |
| SPE2-SPE1-Up | Oxidative phosphorylation | tve00190 | 6 | 53 | 5.28 | 0.004 |
| SPE3-SPE1-Dw | Proteasome | tve03050 | 28 | 33 | 2.39 | 0.000 |
| SPE3-SPE1-Dw | SNARE interactions in vesicular transport | tve04130 | 10 | 13 | 2.17 | 0.045 |
| SPE3-SPE1-Dw | Sulfur metabolism | tve00920 | 10 | 13 | 2.17 | 0.045 |
| SPE4-SPE1-Dw | Proteasome | tve03050 | 28 | 33 | 2.26 | 0.001 |
| SPE4-SPE1-Dw | SNARE interactions in vesicular transport | tve04130 | 11 | 13 | 2.25 | 0.035 |
| SPE4-SPE1-Dw | Fatty acid metabolism | tve01212 | 17 | 25 | 1.81 | 0.038 |
| SPE4-SPE1-Dw | Fructose and mannose metabolism | tve00051 | 16 | 24 | 1.77 | 0.048 |
| SPE4-SPE1-Up | Terpenoid backbone biosynthesis | tve00900 | 4 | 21 | 2.35 | 0.032 |
| SPE4-SPE1-Up | Glycine, serine and threonine metabolism | tve00260 | 5 | 36 | 1.72 | 0.049 |
| SPE3-SPE2-Dw | Spliceosome | tve03040 | 12 | 72 | 4.36 | 0.000 |
| SPE3-SPE2-Dw | Oxidative phosphorylation | tve00190 | 6 | 53 | 2.96 | 0.028 |
| SPE3-SPE2-Dw | Pantothenate and CoA biosynthesis | tve00770 | 3 | 16 | 4.9 | 0.037 |
| SPE3-SPE2-Dw | Valine, leucine and isoleucine biosynthesis | tve00290 | 3 | 16 | 4.9 | 0.037 |
| SPE3-SPE2-Dw | Butanoate metabolism | tve00650 | 3 | 17 | 4.61 | 0.042 |
| SPE3-SPE2-Up | Ribosome biogenesis in eukaryotes | tve03008 | 54 | 66 | 0.95 | 0.039 |
| SPE3-SPE2-Up | Glycine, serine and threonine metabolism | tve00260 | 33 | 36 | 1.06 | 0.039 |
| SPE4-SPE3-Dw | Basal transcription factors | tve03022 | 21 | 28 | 1.25 | 0.049 |
| SPE4-SPE3-Up | Pentose phosphate pathway | tve00030 | 2 | 25 | 3.42 | 0.025 |
Up refers to up-regulated pathway and Dw to down-regulated pathway. DEGs-Size, number of differentially expressed genes that contribute to the enrichment of the term. Size, number of expressed genes associated with the term. RF, rich factor.
Figure 4(a) enriched Glycine, serine and threonine metabolism and (b) enriched Aminoacyl-tRNA biosynthesis pathways with EC numbers found down-regulated in A. apis mutant SPE2 compared SPE1 shown in red color. EC numbers sown in green color are present in Trichophyton verrucosum KEGG database, but not identified in A. apis transcriptome[19].
Figure 6(a) enriched Ribosome biogenesis in eukaryotes pathway found up-regulated in A. apis mutant SPE3 compared to mutant SPE2 shown in red color and (b) enriched basal transcription factors pathway found down-regulated in A. apis mutant SPE4 compared to mutant SPE3 shown in red color[19].
Figure 7Global protein-protein interaction (PPI) networks for differentially expressed genes that altered by REMI mutation involved in nine pathways using STRING database, with COG functions. The nodes represent protein families and the lines represent the existence of the different types of evidence used in predicting the associations. A red line indicates the presence of fusion evidence, a green line shows neighborhood evidence, a blue line for co-occurrence evidence, a purple line indicates experimental evidence, a yellow line for text mining evidence, a light blue line stands for database evidence, and a black line for co-expression evidence.
Figure 8Relative expression of genes validated by qRT-PCR.
Genes used for qRT-PCR analyses.
| Gene ID | Pathway | SPE2-SPE1 | SPE3-SPE1 | SPE4-SPE1 |
|---|---|---|---|---|
| Cluster-9247.0 | Proteasome | −6.5 | −6.5 | −6.5 |
| Cluster-9532.0 | Proteasome | −9.1 | −9.1 | −9.1 |
| Cluster-8451.0 | Proteasome | −9.2 | −9.2 | −9.2 |
| Cluster-8912.1 | Proteasome | −6.3 | −6.3 | −6.3 |
| Cluster-6390.0 | Proteasome | −7.4 | −7.4 | −7.4 |
| Cluster-8037.0 | SNARE interactions | −8.4 | −8.4 | −8.4 |
| Cluster-6594.1 | SNARE interactions | −6.3 | −6.3 | −6.3 |
| Cluster-5886.0 | SNARE interactions | −8.2 | −8.2 | −8.2 |
| Cluster-9231.1 | SNARE interactions | −5.3 | −5.3 | −5.3 |
| Cluster-8386.0 | Fatty acid metabolism | −6.1 | −6.1 | −6.1 |
| Cluster-8610.0 | Fatty acid metabolism | −6.1 | −6.1 | −6.1 |
| Cluster-8189.0 | Fatty acid metabolism | −7.1 | −7.1 | −7.1 |
Primers used to see the expression of genes in qRT-PCR analysis.
| Target gene | Forward primer (5′ to 3′) | Reverse primer (5′ to 3′) | Product size (bp) |
|---|---|---|---|
| Cluster-9247.0 | GATCGACAACCCTCTTCCAA | TAAAACTGCACCGTGTCTCG | 130 |
| Cluster-9532.0 | TGAGGGCTGCTTTCTTCAAT | CAGTGGCAGCTTGTTGTTGT | 114 |
| Cluster-8451.0 | CTCTGCCGGTCTAGTTCCAG | CAGGGATAGGGCCCTTGTAT | 95 |
| Cluster-8912.1 | GGCATCTCGAAAGTCACCTC | TTTGGAAAGCATCCAACTCC | 101 |
| Cluster-6390.0 | TTCCATTGGTGGATCTGGTT | TCCCCGAACAAAGTTAATGC | 100 |
| Cluster-8037.0 | AACGCAAGTTCCTATCCACCT | AGCGGAGCTCATTGTTGAAT | 93 |
| Cluster-6594.1 | TTCCAAGGTCCTCGATGAGT | CCTGGTACGCCGAGATGTAT | 104 |
| Cluster-5886.0 | TACAATTGCAGAGGCAGACG | TAGCAATGCCCAGTTCCTTC | 93 |
| Cluster-9231.1 | GTCTCAGTTCAGCGGACACA | TGACTTTGAAGGAGGGTGCT | 127 |
| Cluster-8386.0 | TGGTTTCCCCGAGACTACTG | ATCATGCCGGACTTGATAGC | 102 |
| Cluster-8610.0 | ACCTGATCCTTGCCATTCTG | ATCGGGATTCGAGTTCTGTG | 111 |
| Cluster-8189.0 | GAGGAGGCGAGTCTGAAATG | GACGTATTGCTGCGAGTTGA | 99 |
| CATGATTGGTATGGGTCAG | CGTTGAAGGTCTCGAAGAC |